21st World Dermatology Congress | March 23-24, 2020 | Tokyo, Japan

Lada Rasochova

doi:10 .4172/2327-4581.1000411

Market Analysis, Clin Dermatol Res J Vol: 4 Issue: 2

21st World Dermatology Congress | March 23-24, 2020 | Tokyo, Japan

Lada Rasochova

CEO of Dermala Inc., USA, E-mail: rasochova@dermala.com

Abstract

Dermatology is the branch of medicine that deals with the Skin, Nails, Hair and its sicknesses. It is a claim to fame with both medical and surgical perspectives. A Dermatologist treats illnesses, in the most extensive sense, and some cosmetic issues of the Skin, Scalp, Hair, and Nails. Conference Series LLC Ltd is organizing 21st World Dermatology Congress during March 23-24, 2020 at Tokyo, Japan. World Dermatology 2020 will raise the most dynamic and latest issues in the field of Dermatology

Keywords: Dermatology Drugs

Download PDF

Market Analysis

Dermatology is the branch of medicine that deals with the Skin, Nails, Hair and its sicknesses. It is a claim to fame with both medical and surgical perspectives. A Dermatologist treats illnesses, in the most extensive sense, and some cosmetic issues of the Skin, Scalp, Hair, and Nails.

Conference Series LLC Ltd is organizing 21^st World Dermatology Congress during March 23-24, 2020 at Tokyo, Japan. World Dermatology 2020 will raise the most dynamic and latest issues in the field of Dermatology. The Congress will highlight the discussion around the theme “Contemporary Modes to Escalate Research in Dermatology” by bridging the gaps between the intellectuals from across the globe to enlighten their research and findings at World Dermatology 2020. The highlights of the conference includes Dermatology, Clinical Dermatology, Pediatric Dermatology, Dermatological Diseases, Psoriasis, Hyperpigmentation and Vitiligo, Leprosy, Skin Cancer, Dermatological Techniques, Alopecia and Scalp Problems and many more.

Dermatology Market:

Majority of the dermatology market has remained saturated with the established products for the past decades. With the advent of promising novel pipeline products, the dermatology market landscape is expected to change substantially. In the year 2015, the global dermatology market was valued at $20.0 billion and it is expected to grow around $33.7 billion in the year 2022.

Including an aging population, rising disposable incomes and growing need for early diagnosis of dermatological conditions, this growth in market size will be attributed to numerous factors. Because of the rising adoption of medical and aesthetic laser technologies, there will be significant increase in the demand for the devices like dermatology lasers. Among which, the countries – US and Brazil are the key countries that has more demand for these dermatology devices.

The dermatology lasers market will grow at CAGR (Compound Annual Growth Rate) of over 15% in the Americas by the year 2023. Also, in Asia-Pacific countries, the demand for these lasers is high.

In Asian countries, the adoption of anti-aging treatments is increasing. Apart from this, countries like France, Germany and Italy are having the major markets for dermatology devices. The global dermatological drugs market was 10.37% in the year 2018.

Dermatology Drugs Market Competitive Landscape:

Regulatory authorities like U.S. Food and Drug Administration (USFDA) and the European Union (EU) have approved various dermatological drugs manufactured by key players. This is positively affecting the growth of the dermatology drugs market.

For example – Priority review for Sanofi’s supplemental Biologics License Application (sBLA) for Dupixent (dupilumab) as potential treatment for adolescent patients (aged 12–17 years) with uncontrolled moderate-to-severe atopic dermatitis has been granted by USFDA in November 2018.